Who owns BioAge Labs, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of BIOA from SEC Form 13F filings across 150 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 150 institutions disclosed 37.7M shares of BioAge Labs, Inc. worth $924.6M — about 84.1% of shares outstanding; the largest disclosed holder is a16z Capital Management, L.L.C.. Source: SEC Form 13F filings, parsed by EvidInvest.
150
13F holders
$924.6M
value, 2026 filers
84.1%
of shares outstanding (37.7M sh)
28
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of BIOA's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | a16z Capital Management, L.L.C. | 3.2M | $79.2M | 0.6% | 7.2% | 0.0% |
| 2 | BlackRock, Inc. | 2.8M | $69.8M | 0.0% | 6.4% | +25.6% |
| 3 | Cormorant Asset Management, LP | 2.4M | $58.6M | 3.0% | 5.3% | -17.3% |
| 4 | Sofinnova Investments, Inc. | 2.3M | $56.2M | 2.9% | 5.1% | 0.0% |
| 5 | Jupiter Topco LLCNEW | 2.1M | $52.6M | 0.0% | 4.8% | new |
| 6 | Octagon Capital Advisors LP | 1.7M | $42.8M | 3.9% | 3.9% | 0.0% |
| 7 | RA CAPITAL MANAGEMENT, L.P. | 1.7M | $41.0M | 0.4% | 3.7% | +1.3% |
| 8 | MPM BIOIMPACT LLCNEW | 1.7M | $40.9M | 2.5% | 3.7% | new |
| 9 | VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | $37.8M | 0.0% | 3.4% | +14.0% |
| 10 | Polar Capital Holdings Plc | 1.1M | $26.3M | 0.1% | 2.4% | -5.3% |
| 11 | BRAIDWELL LP | 1.0M | $25.3M | 0.9% | 2.3% | -13.9% |
| 12 | STATE STREET CORP | 1.0M | $25.0M | 0.0% | 2.3% | +20.0% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.0M | $24.6M | 0.0% | 2.2% | +34.0% |
| 14 | Sands Capital Alternatives, LLC | 786,353 | $19.3M | 3.1% | 1.8% | 0.0% |
| 15 | ORBIMED ADVISORS LLC | 752,153 | $18.4M | 0.3% | 1.7% | +5.7% |
| 16 | D. E. Shaw & Co., Inc. | 742,761 | $18.2M | 0.0% | 1.7% | +6.2% |
| 17 | Balyasny Asset Management L.P. | 702,858 | $17.2M | 0.0% | 1.6% | -47.1% |
| 18 | Pivotal bioVenture Partners Investment Advisor LLC | 653,374 | $16.0M | 5.2% | 1.5% | 0.0% |
| 19 | COSMIC MANAGEMENT, LLC | 501,833 | $12.3M | 3.2% | 1.1% | 0.0% |
| 20 | STEMPOINT CAPITAL LP | 464,171 | $11.4M | 2.0% | 1% | +37.1% |
| 21 | VANGUARD PORTFOLIO MANAGEMENT LLC | 410,165 | $10.1M | 0.0% | 0.9% | +42.9% |
| 22 | DIMENSIONAL FUND ADVISORS LP | 394,138 | $9.7M | 0.0% | 0.9% | +83.7% |
| 23 | JACOBS LEVY EQUITY MANAGEMENT, INC | 377,085 | $9.2M | 0.0% | 0.8% | -10.2% |
| 24 | Walleye Capital LLC | 354,395 | $8.7M | 0.0% | 0.8% | +133.7% |
| 25 | Nuveen, LLC | 349,142 | $8.6M | 0.0% | 0.8% | +617.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.